Ardent Health Partners (NYSE:ARDT) Reaches New 1-Year Low – Time to Sell?

Shares of Ardent Health Partners, LLC (NYSE:ARDT) hit a new 52-week low during trading on Friday . The stock traded as low as $13.63 and last traded at $13.98, with a volume of 54957 shares traded. The stock had previously closed at $15.16.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on ARDT. Bank of America cut shares of Ardent Health Partners from a “buy” rating to a “neutral” rating and dropped their target price for the company from $22.00 to $19.00 in a research note on Wednesday, November 6th. Leerink Partners upped their price objective on Ardent Health Partners from $23.00 to $25.00 and gave the company an “outperform” rating in a research note on Tuesday, November 12th. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $20.00 target price on shares of Ardent Health Partners in a research report on Tuesday, December 17th. Morgan Stanley lowered their target price on Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 21st. Finally, Stephens reiterated an “overweight” rating and set a $22.00 price target on shares of Ardent Health Partners in a research note on Thursday. Two analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, Ardent Health Partners currently has an average rating of “Buy” and a consensus target price of $21.36.

Ardent Health Partners Stock Performance

The business has a fifty day moving average of $15.23 and a 200-day moving average of $16.84. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91.

Ardent Health Partners (NYSE:ARDT) last issued its quarterly earnings data on Wednesday, February 26th. The company reported $0.81 EPS for the quarter, beating the consensus estimate of $0.50 by $0.31. The firm had revenue of $1.61 billion for the quarter, compared to analysts’ expectations of $1.48 billion. As a group, research analysts expect that Ardent Health Partners, LLC will post 1.23 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the company. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of Ardent Health Partners during the 4th quarter valued at about $27,000. US Bancorp DE bought a new stake in Ardent Health Partners during the fourth quarter valued at approximately $31,000. R Squared Ltd purchased a new position in Ardent Health Partners in the 4th quarter worth approximately $37,000. BNP Paribas Financial Markets bought a new position in shares of Ardent Health Partners in the 3rd quarter worth $42,000. Finally, New York State Common Retirement Fund bought a new position in shares of Ardent Health Partners in the 4th quarter worth $48,000.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.